LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 89.57 | 84.90 | 1742 | 7494 | 0.2324 | 0.5959 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 89.57 | 84.90 | 79 | 7494 | 0.0105 | -0.0111 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 89.57 | 84.90 | 1784 | 7494 | 0.2380 | 0.6018 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 91.27 | 84.90 | 161 | 7420 | 0.0217 | 0.1043 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 91.27 | 84.90 | 1749 | 7420 | 0.2357 | 0.5985 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 91.27 | 84.90 | 96 | 7420 | 0.0129 | 0.0192 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 91.27 | 84.90 | 1814 | 7420 | 0.2445 | 0.6076 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 92.98 | 84.90 | 166 | 7257 | 0.0229 | 0.1101 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 92.98 | 84.90 | 1777 | 7257 | 0.2449 | 0.6062 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 92.98 | 84.90 | 84 | 7257 | 0.0116 | -0.0017 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 92.98 | 84.90 | 1856 | 7257 | 0.2557 | 0.6172 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 94.68 | 84.90 | 153 | 7000 | 0.0219 | 0.0969 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 94.68 | 84.90 | 1782 | 7000 | 0.2546 | 0.6132 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 94.68 | 84.90 | 75 | 7000 | 0.0107 | -0.0193 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 94.68 | 84.90 | 1906 | 7000 | 0.2723 | 0.6303 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 2.66 | 84.90 | 432 | 285 | 1.5119 | 1.5325 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 2.66 | 84.90 | 533 | 285 | 1.8653 | 1.8554 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 4.36 | 84.90 | 528 | 322 | 1.6368 | 1.5832 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 4.36 | 84.90 | 598 | 322 | 1.8539 | 1.7557 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 6.06 | 84.90 | 608 | 365 | 1.6637 | 1.5469 | MN20160318_Q02 | F05 |